Other mucins, such as MUC1 (breast cancer) or prostate specific antigen (PSA, prostate cancer), have been used for cancer detection and progression monitoring, however, their sensitivity and specificity are limited. This evidence concerns the gene MUC1 and prostate carcinoma.